This information
collection is approved for three years subject to the following
terms of clearance: 1. Prior to resubmission, the agency shall
coordinate with NIDA, ONDCP, DEA, and FDA in evaluating the need
for a redesign of the DAWN sampling frame in order to ensure that
it is representative of the medical health care delivery system for
drug abuse. 2. As part of resubmission, the agency shall address
the results of this evaluation and incorporate any recommendations
into the information collection. 3. Prior to resubmission,
coordinate with CDC in order to minimize duplication with the
National Ambulatory Care Survey (NHACS). 4. Prior to resubmission,
the agency shall undertake efforts to use information technology to
reduce reporting burden, and shall address these efforts as part of
resubmission.
Inventory as of this Action
Requested
Previously Approved
04/30/2000
04/30/2000
04/30/1997
202,450
0
170,611
15,972
0
22,207
0
0
0
The Drug Abuse Warning Network
collects data on drug-related medical emergencies and deaths as
reported from about 650 hospitals and medical examiners nationwide.
Used by Federal, State, and local agencies, this ongoing data
system supports efforts to identify drug abuse trends, asseses
health hazards associated with substance abuse, and schedules
substances under the Controlled Substances Act.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.